MF
Medicortex Finland is developing a non-invasive, point-of-care diagnostic test that utilizes biomarker analysis to detect Traumatic Brain Injury (TBI) and assess its severity. This technology addresses the critical lack of reliable diagnostic tools for TBI, providing healthcare professionals with a valid method for timely diagnosis and treatment planning.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Medicortex Finland is developing a non-invasive, point-of-care diagnostic test that utilizes biomarker analysis to detect Traumatic Brain Injury (TBI) and assess its severity. This technology addresses the critical lack of reliable diagnostic tools for TBI, providing healthcare professionals with a valid method for timely diagnosis and treatment planning.